Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOn your first day on Mounjaro, you inject 2.5 mg of tirzepatide — a starter dose designed to let your body adjust, not to produce immediate weight loss. Most people feel little or nothing in the first 24 hours; others notice mild nausea or a reduced appetite by evening. Mounjaro is a prescription-only medicine, and a clinician reviews every consultation before it is issued. Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) which slow gastric emptying and dampen appetite signals. The effects build over weeks as the dose increases, so day one is a beginning, not a benchmark.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people inject their first pen expecting something obvious, a sudden loss of appetite, an immediate shift in how food feels, maybe a headache or fatigue that signals the medicine is working. That is not usually how it goes.
The 2.5 mg opening dose exists for one reason: your digestive system needs time to adapt to a medicine that slows gastric emptying and alters gut-hormone signalling. Therapeutic weight-loss effects come later, once the prescriber has taken you through the titration schedule toward your maintenance dose. Starting at 2.5 mg is standard practice, confirmed in the NHS tirzepatide guidance, and skipping ahead or measuring results at this point is counterproductive.
Some people do notice something on day one. A dull background nausea, a slightly smaller appetite at dinner, a feeling of fullness after a smaller portion than usual. These are all normal early signals. Others notice absolutely nothing, and that is equally normal. Neither outcome tells you how the medicine will perform for you over the coming months.
If you feel anxious or underwhelmed today, you are in good company. The first injection is often more nerve-racking than medically significant. Give it time.
Inject at a consistent time each week. Many people pick a day and time that fits a routine, a Saturday morning, after work on a Tuesday. The exact day matters less than the consistency.
After the injection, carry on eating normally, but pay attention. The most common early side effects are gastrointestinal: nausea, burping, a sense of fullness, loose stools, or mild constipation. These are more likely if you eat a large or fatty meal shortly after injecting, so a lighter meal on injection day is sensible, not medically mandated, just practical. Staying well hydrated helps.
For the first 24 hours, your day one experience is mainly about observing rather than reacting. Note how you feel. If nausea is significant, small frequent meals and plain foods tend to help. If it is severe, persistent, or accompanied by intense stomach pain radiating to the back, contact a healthcare professional promptly, that pattern warrants assessment for pancreatitis, as the MHRA's Drug Safety Update index records as a known but infrequent risk with GLP-1 medicines.
Injection-site redness or mild itching is common and usually resolves quickly. If you experience difficulty breathing, swelling of the face, or signs of a serious allergic reaction, seek urgent medical help.
After your injection, the pen goes straight back into the fridge, 2–8 °C, away from the freezer compartment. Room-temperature storage is permitted for a limited window, but for the exact timeframe refer to the Patient Information Leaflet inside your pack rather than relying on any general guidance. The pen is pre-filled with four weekly doses, so you will use it again next week at the same time.
The week ahead is when things become more informative. The first week on Mounjaro typically gives you a clearer picture of how your body responds, whether the appetite suppression starts to register, whether GI side effects fade or persist, and how your energy levels settle. By day three many people notice the nausea, if any, beginning to ease, and what happens on day two can help set realistic expectations for that early transition.
The dose will stay at 2.5 mg for four weeks before your prescriber reviews and adjusts. That review matters, it is not automatic or algorithmic. At nume, a named GPhC-registered prescriber looks at your progress before any dose change is approved. You can read more about our clinical team on the clinical team page.
If you have not yet started treatment and are weighing up the practicalities, our Mounjaro pricing page lays out what the cost of private treatment covers in plain terms. And if you are ready to begin, starting a free consultation is the first step toward a same-day clinical review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.